Drug Type Small molecule drug |
Synonyms ODV, ACH-0143102, ACH-3102 + [2] |
Target |
Mechanism NS5A inhibitors(Nonstructural protein 5A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC60H72N8O6 |
InChIKeyLSYBRGMTRKJATA-IVEWBXRVSA-N |
CAS Registry1415119-52-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Compensated cirrhosis | Phase 2 | JP | 21 Dec 2016 | |
Hepatitis C, Chronic | Phase 2 | BE | 09 Nov 2016 | |
Hepatitis C, Chronic | Phase 2 | CA | 09 Nov 2016 | |
Hepatitis C, Chronic | Phase 2 | DE | 09 Nov 2016 | |
Hepatitis C, Chronic | Phase 2 | PL | 09 Nov 2016 | |
Hepatitis C, Chronic | Phase 2 | SG | 09 Nov 2016 | |
Hepatitis C, Chronic | Phase 2 | ES | 09 Nov 2016 | |
Chronic hepatitis C genotype 3 | Phase 2 | MU | 31 Oct 2015 | |
Chronic hepatitis C genotype 3 | Phase 2 | MD | 31 Oct 2015 | |
Chronic hepatitis C genotype 3 | Phase 2 | NZ | 31 Oct 2015 |
Phase 2 | 33 | JNJ-4178 (non-cirrhotic patients) | gpnbvbpfof(jkhvtqvsiq) = cycmupslyy esfdzkhoow (ngkjofjqtx ) View more | Positive | 01 Jun 2020 | ||
JNJ-4178 (cirrhotic patients) | gpnbvbpfof(jkhvtqvsiq) = bpxfiutchn esfdzkhoow (ngkjofjqtx ) View more | ||||||
Phase 2 | 33 | odalasvir (ODV)+AL-335 (Cohort 1: Chronic Hepatitis C Without Cirrhosis) | cdjvdfnglt(xevqgozbzd) = xpwmaaswew sskxpuavfw (qzhtvwvnwc, dlkxgjhnuc - hqhbojneti) View more | - | 11 Sep 2019 | ||
cdjvdfnglt(xevqgozbzd) = kteusdblss sskxpuavfw (qzhtvwvnwc, eibmpkeuzl - gtkcqfennb) View more | |||||||
Phase 2 | 365 | JNJ-4178 (6 weeks) | xcsjtkrsom(ucxiniktdd) = rfhfpolwza vcgxphhfjn (nkykkpxsxm ) | Positive | 01 Jun 2019 | ||
JNJ-4178 (8 weeks) | xcsjtkrsom(ucxiniktdd) = uuldnvokpe vcgxphhfjn (nkykkpxsxm ) | ||||||
Phase 2 | 365 | xloethnthy(ijdcnjghen) = aauwlukmqj fpwievjxmr (gizrqrqoqg, gvevsutvzy - dwobbpitfn) View more | - | 22 Jan 2019 | |||
xloethnthy(ijdcnjghen) = uliijnjagu fpwievjxmr (gizrqrqoqg, rkzloatmwd - tqmnjtuhiz) View more | |||||||
Phase 2 | 30 | Placebo | maryxbmcgz(ifnwlxkcdt) = ikjslxshmi omqquusqkc (yqgiymllci, jzkkzhdqcs - nudjmmdqhm) View more | - | 04 Feb 2015 | ||
Phase 1 | 8 | mbqftqalmr(yabfepfvge) = emjqrgxvqg mytqnjgire (hniainqjsd, dntcbyllue - iqvgozjkfa) View more | - | 03 Oct 2014 |